Начало・Списък с акции・Twist Bioscience Corp

Twist Bioscience Corp

Затворен

СекторЗдравеопазване

108.46 -5

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

108.24

Максимум

114.17

Ключови измерители
By Trading Economics
Приходи	9M -35M
Продажби	7.7M 118M
EPS	-0.56
Марж на печалбата	-29.61
Служители	979
EBITDA	1.5M -36M

Препоръки
By TipRanks
Препоръки	Силна покупка
12-месечна прогноза	-4.46% downside

Пазарни показатели
By TradingEconomics
Пазарна капитализация	2.8B 6.3B
Предишно отваряне	113.46
Предишно затваряне	108.46

Настроения в новините

By Acuity

69%

31%

306 / 340 Класиране в Healthcare

Twist Bioscience Corp Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

5.08.2026 г., 23:56 ч. UTC

Twist Bioscience Corp shares rose in after-market trading, despite earlier declines. Market sentiment was affected by a disappointing ADP employment report.

4.08.2026 г., 23:01 ч. UTC

News

Twist Bioscience announced a $250 million public offering, raising concerns over potential dilution. Shares are trading lower in after-market hours following the announcement.

3.08.2026 г., 22:16 ч. UTC

Twist Bioscience Corp shares are lower in after-market hours, despite an initial gain following Monday's close. No specific news was identified to explain the decline.

31.07.2026 г., 19:56 ч. UTC

Twist Bioscience shares are higher, reflecting positive sentiment in biotechnology amid strong results from major technology firms like Amazon.

30.07.2026 г., 10:16 ч. UTC

Twist Bioscience Corp is trading slightly higher in pre-market hours, recovering from a decline in the previous session amid broader tech stock volatility.

29.07.2026 г., 19:36 ч. UTC

Correlated Moves

Macro Event

Twist Bioscience shares are lower today, influenced by a declining Russell 2000 Index and persistent inflation concerns amid steady interest rates.

28.07.2026 г., 21:56 ч. UTC

Twist Bioscience Corp shares are trading lower in after-market hours. Broader market trends, including declines in Asian semiconductor stocks, may be influencing this movement.

27.07.2026 г., 19:33 ч. UTC

Twist Bioscience Corp shares are lower today, continuing a recent downward trend. The stock pulled back significantly after reaching a session high.

24.07.2026 г., 15:24 ч. UTC

Twist Bioscience Corp shares are lower today, reversing a recent trend of gains. High trading volume accompanies the decline amid mixed economic signals.

21.07.2026 г., 20:02 ч. UTC

Correlated Moves

Twist Bioscience Corp is advancing today, supported by high trading volume and renewed investor interest in technology and AI stocks, despite a pullback earlier in the session.

20.07.2026 г., 23:06 ч. UTC

Twist Bioscience Corp shares are higher in after-market trading, though no specific news was identified to explain the movement. The stock remains below its 20-day moving average.

Сравнение с други в отрасъла

Ценова промяна

Twist Bioscience Corp Прогноза

Ценова цел

By TipRanks

-4.46% надолу

12-месечна прогноза

Среден 109.88 USD -4.46%

Висок 120 USD

Нисък 95 USD

Според 9 анализатори от Wall Street, предложили 12-месечна ценова цел за Twist Bioscience Corp през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

9 ratings

Купи

Задържане

Продай

Според 9 анализатори, дали борсови рейтинги на Twist Bioscience Corp през последните 3 месеца.

Настроение

By Acuity

306 / 340 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Twist Bioscience Corp

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on the pursuit of drug discovery and development. It also provides NGS tools comprising library preparation kits, human exome kits, and fixed and custom panels, as well as alliance panels used within diagnostic tests for various indications, population genetics research and biomarker discovery, translational research, microbiology, and applied markets research; and methylation detection kits for cancer, and rare and inherited disease study, as well as fast hybridization and full RNA sequencing workflow solution. In addition, it offers synthetic SARS-CoV-2 RNA reference sequences as positive controls to develop both NGS and reverse transcription-polymerase chain reaction assays; synthetic monkeypox controls; and various respiratory viral controls, including for influenzas, respiratory syncytial virus, rhinoviruses, SARS, MERS, and coronaviruses. Further, it offers SARS-CoV-2 Research Panels, such as the Twist Respiratory Virus Panel and the Pan-Viral Research Panel, for the detection of disease in a research setting; precision DNA libraries for antibody engineering, affinity maturation, and humanization; and antibody optimization solution to enable simultaneous optimization of multiple characteristics of a given antibody. The company has a strategic collaboration with bitBiome Inc. The company was incorporated in 2013 and is headquartered in South San Francisco, California.